Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Edwards expands D.C. presence: Dirksen Lehman and Barry Liden are heading up Edwards Lifesciences' Washington, D.C., government affairs office, the firm announces Oct. 26. Lehman, the new VP-government affairs, joins Edwards from consulting firm Clark & Weinstock, where he led the health care practice. He previously served as special assistant to the President for legislative affairs as the White House's primary liaison to the Senate for health care issues (1"The Gray Sheet" Feb. 5, 2001, p. 24). Liden, director for government affairs, joined the firm in 2002. He previously was director of external communications and most recently directed the firm's state government affairs operations from the Irvine, Calif., headquarters. Edwards says the D.C. office will support the company's growing role in AdvaMed, of which CEO Michael Mussallem becomes chairman in 2008 (2"The Gray Sheet" March 12, 2007, In Brief)

You may also be interested in...

Dirksen Lehman

President Bush announces Jan. 30 his intention to name Senate Health Committee staff health counsel Lehman as a special assistant for legislative affairs for the Senate. Lehman will work as one of the Senate lobbyists in the White House Office of Legislative Affairs, reporting to chief Senate lobbyist Ziad Ojakli, former chief of staff to Sen. Paul Coverdell (R-Ga.). Before joining the Health Committee staff in 1999, Lehman was with Washington lobbying firm Williams & Jensen. The Health Committee has not yet named a replacement

Celltrion Makes Progress On Coronavirus Treatment

Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.

Spain Lists Certain OTCs As 'Essential' In Fight Against COVID-19

Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts